Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment - PubMed (original) (raw)

Comparative Study

Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment

Gail Ironson et al. Psychosom Med. 2005 Nov-Dec.

Abstract

Objective: Most previous longitudinal studies demonstrating relationships between psychosocial variables and human immunodeficiency virus (HIV) disease progression utilized samples of gay men accrued before the era of highly active antiretroviral treatment (HAART), without including viral load (VL) as an indicator of disease progression or assessing the impact of medication adherence. This study sought to determine whether psychosocial variables would predict both CD4 and VL changes in a diverse sample assessed entirely during the era of HAART and accounting for adherence effects.

Methods: This longitudinal study assessed a multiethnic HIV+ sample (n = 177) of men and women in the midrange of illness (CD4 number between 150 and 500; no previous acquired immunodeficiency syndrome [AIDS]-defining symptom) every 6 months for 2 years. Hierarchical linear modeling was used to model change in CD4 and VL controlling for sociodemographics (age, gender, ethnicity, education) and medical variables (baseline CD4/VL, antiretroviral medications at each time point, adherence).

Results: Baseline depression, hopelessness, and education predicted the slope of CD4 and VL. Avoidant coping and life event stress predicted VL change. Cumulative variables produced stronger relationships (depression, avoidant coping, and hopelessness with CD4/VL slope and life events stress with VL slope). High cumulative depression and avoidant coping were associated with approximately twice the rate of decline in CD4 as low scorers and greater relative increases in VL. Social support was not significantly related to CD4 or VL slope.

Conclusions: Psychosocial factors contribute significantly to the variance in HIV disease progression (assessed through CD4 number and VL) in a diverse sample, accounting for adherence and do so in the era of HAART.

PubMed Disclaimer

Cited by

Critical Review: When the Party is Over: A Systematic Review of Behavioral Interventions for Substance-Using Men Who Have Sex with Men.
Carrico AW, Zepf R, Meanley S, Batchelder A, Stall R. Carrico AW, et al. J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):299-306. doi: 10.1097/QAI.0000000000001102. J Acquir Immune Defic Syndr. 2016. PMID: 27258233 Free PMC article. Review.
How have long-term survivors coped with living with HIV?
Slomka J, Lim JW, Gripshover B, Daly B. Slomka J, et al. J Assoc Nurses AIDS Care. 2013 Sep-Oct;24(5):449-59. doi: 10.1016/j.jana.2012.09.004. Epub 2012 Dec 17. J Assoc Nurses AIDS Care. 2013. PMID: 23253776 Free PMC article.
Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States.
Pence BW, Mills JC, Bengtson AM, Gaynes BN, Breger TL, Cook RL, Moore RD, Grelotti DJ, O'Cleirigh C, Mugavero MJ. Pence BW, et al. JAMA Psychiatry. 2018 Apr 1;75(4):379-385. doi: 10.1001/jamapsychiatry.2017.4726. JAMA Psychiatry. 2018. PMID: 29466531 Free PMC article.
Prevalence of depression or depressive symptoms among people living with HIV/AIDS in China: a systematic review and meta-analysis.
Wang T, Fu H, Kaminga AC, Li Z, Guo G, Chen L, Li Q. Wang T, et al. BMC Psychiatry. 2018 May 31;18(1):160. doi: 10.1186/s12888-018-1741-8. BMC Psychiatry. 2018. PMID: 29855289 Free PMC article.
Mindfulness meditation training effects on CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial.
Creswell JD, Myers HF, Cole SW, Irwin MR. Creswell JD, et al. Brain Behav Immun. 2009 Feb;23(2):184-8. doi: 10.1016/j.bbi.2008.07.004. Epub 2008 Jul 19. Brain Behav Immun. 2009. PMID: 18678242 Free PMC article. Clinical Trial.

References

1. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568–2573. - PubMed
1. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W., Jr Co-morbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Ann Epidemiol. 1996;6:420–430. - PubMed
1. Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, Cai J, Folds JD, Evans DL. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397–406. - PubMed
1. Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, Perkins DO, Folds JD, Evans DL. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32:1059–1073. - PubMed
1. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54:295–306. - PubMed

Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment - PubMed (original) (raw)